A conversation with Fran Díaz, founder of Autofabricantes in Spain, on including users in the design process for 3D printed prostheses.
Category: entrepreneurs
Julie Van Ongevalle On Sanofi Consumer Healthcare’s Road To Sustainability And B Corp Certification
B Corp Certification demands significant dedication. Julie Van Ongevalle EVP of Sanofi discusses is effects on workforce, environmental sustainability and consumers.
Next Billion-Dollar Startups 2023: AI And Data Dominate This Year’s List
The market’s obsession with data science and artificial intelligence is reflected in this year’s list of 25 companies we think most likely to reach $1 billion valuation.
Truepill’s Sid Viswanathan Out As CEO As Troubles Mount At Tech-Enabled Pharmacy
Not quite 18 months after being named CEO of Truepill, cofounder Sid Viswanathan is gone. The company, worth $1.6 billion at its last equity funding round, faces an uncertain future with a cash squeeze and DEA investigation.
Theator Raises $40M To Improve Surgery Outcomes For Patients, Doctors, And Hospitals
Tamir Wolf created Theator to improve surgical outcomes for patients, doctors and hospitals. His startup story has three protagonists — each with their own compelling narrative. The story challenge is in weaving the three together.
Extending The Human Life Span By A Decade Within A Decade
Can precision genomics, AI, and a new perspective on preventive medicine achieve extending the human life span by a decade within a decade?
First Outside Investment In 30 Years Makes Life Sciences Software Firm A Unicorn
Salt Lake City-based MasterControl built its business under the radar for decades. Now the company is worth $1.3 billion.
“Every Tragedy Should Be Turned Into A Business Opportunity,” Says BioTech Entrepreneur
Dina Radenkovic, Cofounder & CEO of Gameto, joins the Forbes 30 Under 30 Class of 2023.
Meet The Entrepreneurs Who Designed Pollution-Killing Plants
Neoplants’ super-plants can help clear indoor air of formaldehyde and other pollutants 30 times better than regular houseplants.
In The Costly U.S. Health Care Market, Mark Cuban’s Company Has A Plan To Reduce Prescription Drug Costs
By operating transparently as a public benefit corporation, Mark Cuban Cost Plus Drug Company aims to expand affordable access to medication and help to reshape the $4.1 trillion U.S. health care industry.
